Literature DB >> 26891684

Determination of a steroid profile in heel prick blood using LC-MS/MS.

Anita Boelen1, An F C Ruiter1, Hedi L Claahsen-van der Grinten2, Erik Endert1, Mariette T Ackermans1.   

Abstract

BACKGROUND: The aim of this study was to improve the sensitivity of the congenital adrenal hyperplasia (CAH) neonatal screening by including second-tier steroid profiling on a DBS using LC-MS.
RESULTS: We developed a method to measure the steroid profile in DBS and established gestational age-specific reference ranges of cortisol, cortisone, 11-deoxycortisol, 21-deoxycortisol, 17-hydroxyprogesterone, testosterone, Δ4-androstenedione, corticosterone and 11-deoxycorticosterone using 450 heel prick samples of neonates, participating in the Dutch Screening Program. Analyzing 92 cards with a positive CAH screening showed that only 21-deoxycortisol was 100% specific for diagnosed CAH patients.
CONCLUSION: Steroid precursors can be measured in DBS and we suggest to implement the method as a second tier testing for CAH in The Netherlands.

Entities:  

Keywords:  21-hydroxylase deficiency; DBS; MRM; dutch neonatal screening program; gestational age; reference range

Mesh:

Substances:

Year:  2016        PMID: 26891684     DOI: 10.4155/bio.16.6

Source DB:  PubMed          Journal:  Bioanalysis        ISSN: 1757-6180            Impact factor:   2.681


  5 in total

Review 1.  Congenital Adrenal Hyperplasia-Current Insights in Pathophysiology, Diagnostics, and Management.

Authors:  Hedi L Claahsen-van der Grinten; Phyllis W Speiser; S Faisal Ahmed; Wiebke Arlt; Richard J Auchus; Henrik Falhammar; Christa E Flück; Leonardo Guasti; Angela Huebner; Barbara B M Kortmann; Nils Krone; Deborah P Merke; Walter L Miller; Anna Nordenström; Nicole Reisch; David E Sandberg; Nike M M L Stikkelbroeck; Philippe Touraine; Agustini Utari; Stefan A Wudy; Perrin C White
Journal:  Endocr Rev       Date:  2022-01-12       Impact factor: 19.871

2.  Analysis of a pitfall in congenital adrenal hyperplasia newborn screening: evidence of maternal use of corticoids detected on dried blood spot.

Authors:  Muriel Houang; Thao Nguyen-Khoa; Thibaut Eguether; Bettina Ribault; Séverine Brabant; Michel Polak; Irène Netchine; Antonin Lamazière
Journal:  Endocr Connect       Date:  2022-06-15       Impact factor: 3.221

3.  Measurement of 17-Hydroxyprogesterone by LCMSMS Improves Newborn Screening for CAH Due to 21-Hydroxylase Deficiency in New Zealand.

Authors:  Mark R de Hora; Natasha L Heather; Tejal Patel; Lauren G Bresnahan; Dianne Webster; Paul L Hofman
Journal:  Int J Neonatal Screen       Date:  2020-01-28

4.  Neonatal Hormone Concentrations and Risk of Testicular Germ Cell Tumors (TGCT).

Authors:  Libby M Morimoto; David Zava; Katherine A McGlynn; Frank Z Stanczyk; Alice Y Kang; Xiaomei Ma; Joseph L Wiemels; Catherine Metayer
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2018-02-23       Impact factor: 4.090

5.  Evaluation of a Two-Tier Screening Pathway for Congenital Adrenal Hyperplasia in the New South Wales Newborn Screening Programme.

Authors:  Fei Lai; Shubha Srinivasan; Veronica Wiley
Journal:  Int J Neonatal Screen       Date:  2020-08-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.